Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Other Net Income (Loss) : E£0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Macro Group Pharmaceuticals (Macro Capital) Co Other Net Income (Loss)?

Macro Group Pharmaceuticals (Macro Capital) Co's Other Net Income (Loss) for the three months ended in Sep. 2024 was E£-0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was E£0.0 Mil.

Macro Group Pharmaceuticals (Macro Capital) Co's quarterly Other Net Income (Loss) increased from Sep. 2023 (E£-0.0 Mil) to Jun. 2024 (E£0.0 Mil) but then declined from Jun. 2024 (E£0.0 Mil) to Sep. 2024 (E£-0.0 Mil).

Macro Group Pharmaceuticals (Macro Capital) Co's annual Other Net Income (Loss) increased from Dec. 2020 (E£-0.0 Mil) to Dec. 2021 (E£0.0 Mil) but then declined from Dec. 2021 (E£0.0 Mil) to Dec. 2022 (E£0.0 Mil).

Macro Group Pharmaceuticals (Macro Capital) Co Other Net Income (Loss) Historical Data

The historical data trend for Macro Group Pharmaceuticals (Macro Capital) Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Macro Group Pharmaceuticals (Macro Capital) Co Other Net Income (Loss) Chart

Macro Group Pharmaceuticals (Macro Capital) Co Annual Data

Trend

Dec20

Dec21

Dec22

Other Net Income (Loss)

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Jun24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial								-14.59	-	-	-	-

Macro Group Pharmaceuticals (Macro Capital) Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0.0 Mil.

Macro Group Pharmaceuticals (Macro Capital) Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Macro Group Pharmaceuticals (Macro Capital) Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Macro Group Pharmaceuticals (Macro Capital) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY

Website

https://www.macro-egy.com

Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.